Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice

Pharmacokinetics and tolerability of a novel long-acting glucagon-like peptide-1 analog, CJC-1131, in healthy and diabetic subjects

(2011) R.G. Tiessen et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

High-Fat, High-Cholesterol Diet Raises Plasma HDL Cholesterol: Studies on the Mechanism of This Effect

(2010) George Wolf   NUTRITION REVIEWS

Diabesity: therapeutic options

(2009) S. Colagiuri   DIABETES OBESITY & METABOLISM

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

(2009) John B Buse et al.   LANCET

Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: Role of bioactive TNF and Th1 type cytokines

(2008) Maria L. Olleros et al.   CYTOKINE

Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth

(2008) N. Kloting et al.   DIABETES

Gut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity

(2008) Benjamin C T Field et al.   DRUGS

Metabolic Remodeling in Adipocytes Promotes Ciliary Neurotrophic Factor-Mediated Fat Loss in Obesity

(2008) Seamus Crowe et al.   ENDOCRINOLOGY

Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue — Interactions with insulin

(2008) Stina M. Johansson et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice

(2008) Haoran Su et al.   PLoS One